Microalgae Active Outperforms Hyaluronic Acid in Clinical Trial

Lucas Meyer Cosmetics, the specialty ingredients division of Clariant, unveiled AlgaSurge at in-cosmetics Global 2026 in Paris this week. The ingredient — a sulfated polysaccharide hydrogel derived from the red microalga Porphyridium cruentum — outperformed a 1% hyaluronic acid blend in a 90-volunteer clinical trial over 28 days, delivering 57% greater skin plumpness, 34% improved radiance, and 67% wrinkle reduction, according to Lucas Meyer Cosmetics' published efficacy data. The ingredient functions simultaneously as a vegan alternative to PDRN, positioning it as a single active replacing two established but limited skincare standards.

The Case Against Hyaluronic Acid's Durability

Hyaluronic acid performs well as a humectant. Its molecular weight variants — high, low, and oligomeric — hydrate at different skin depths, and its tolerability profile is well established. What HA does not do is last. The enzyme hyaluronidase, naturally present in skin tissue, degrades hyaluronic acid at a rate that shortens its effective window. Formulators have compensated with higher concentrations and complex molecular weight blends, but the fundamental limitation remains: HA hydrates, it does not regenerate.

PDRN — polydeoxyribonucleotide extracted from salmon or trout DNA — addressed the regenerative gap. In aesthetic medicine, PDRN attracted attention for its ability to activate purinergic A2A receptors, promoting tissue repair and collagen synthesis. Its limitations are different: animal sourcing, batch-to-batch variation, cold-chain dependency, and cost that prices it out of most mass-market formulations.

AlgaSurge was developed to work around both sets of constraints. The ingredient derives from Porphyridium cruentum, an extremophile red microalga cultivated in bioreactors through blue biotechnology — no animal origin, no supply chain fragility. Its sulfated polysaccharides resist enzymatic breakdown by hyaluronidase, giving them a longer skin residency than conventional HA.

How Does AlgaSurge Compare to Hyaluronic Acid at the Molecular Level?

AlgaSurge contains sulfated polysaccharides from Porphyridium cruentum that resist hyaluronidase degradation, extending their active window beyond standard HA. Its high molecular weight fractions form a surface protective film; lower molecular weight fractions — including PDRN-analogous components — penetrate to fibroblasts and stimulate collagen synthesis, hyaluronic acid production, and autophagic repair in aged cells.

The clinical separation from HA comes from this two-fraction architecture. Where HA draws water to the skin's upper layers, AlgaSurge's lower molecular weight components reach fibroblasts and initiate downstream cellular responses. According to Clariant's announcement at in-cosmetics Global 2026, lab data show a 50% increase in hyaluronic acid synthesis within fibroblasts treated with AlgaSurge — meaning the ingredient not only delivers surface hydration but prompts the skin to produce its own HA. Collagen I production rose 26%; collagen III by 18%.

The autophagy finding is the most clinically significant. Autophagy — the cell's mechanism for clearing damaged organelles and proteins — declines with age, contributing to the cellular debris accumulation that characterizes aged skin. Lucas Meyer Cosmetics reports that AlgaSurge restored autophagic flux in aged fibroblasts by 16%, a level the company equates to reverting fibroblast behavior to that of 23-year-old skin. On inflammation, IL-8 — a cytokine linked to chronic low-grade skin inflammation and implicated in photoaging — decreased 48% in treated cells.

The 90-volunteer clinical study ran for 28 days, comparing 1% AlgaSurge against a 1% hyaluronic acid blend and placebo. Results appeared after a single application, with improvements in plumpness, density, and barrier function continuing to accumulate across the study duration.

When Will AlgaSurge Reach Consumer Skincare Products?

Lucas Meyer Cosmetics is completing its commercial launch circuit with a second industry showing at NYSCC Suppliers' Day 2026 in New York on May 19-20. In-cosmetics Global serves as the primary platform where finished-goods brands evaluate raw material partnerships; formulation licensing typically follows within months of these shows, with consumer products arriving 12 to 18 months later depending on brand development timelines.

AlgaSurge's launch is one of several next-generation alternative actives that debuted at in-cosmetics Global 2026 this week — a pattern consistent with the skin longevity category's growing formulation investment. Brands willing to move quickly on licensing agreements will have a meaningful window to differentiate before AlgaSurge reaches broader market saturation.